Apollo inks €3B equity deal for stake in Bayer’s contraceptives business
Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal to…
Bayer CEO Anderson sticking out firm’s revitalization scheme
With Bayer’s pharma sales growth lagging behind its crop science and consumer health divisions in the second quarter,…
Silexion Therapeutics Receives Approval from Germany’s
CTA Approval from Germany’s Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from…
Curaleaf Completes Buyout of Remaining Stake in Germany’s Four 20 Pharma
STAMFORD, Conn., April 30, 2026 /PRNewswire/ — Curaleaf Holdings, Inc (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a…